What is the recommended dosage of Cardura (doxazosin) for an older adult male patient with Benign Prostatic Hyperplasia (BPH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cardura (Doxazosin) Dosing for BPH

Start doxazosin at 1 mg once daily (morning or evening), then titrate at 1-2 week intervals through 2 mg, 4 mg, up to a maximum of 8 mg once daily based on symptom response and tolerability. 1

Initial Dosing and Titration

  • Begin with 1 mg once daily as the FDA-approved starting dose for BPH, which can be taken either in the morning or evening 1
  • Titrate upward at 1-2 week intervals to 2 mg, then 4 mg, and finally 8 mg once daily depending on the patient's urodynamic response and symptom improvement 1
  • The maximum recommended dose is 8 mg once daily for BPH treatment 1
  • Monitor blood pressure for at least 6 hours after the initial dose and each dose increase to detect orthostatic hypotension 1

Important Safety Considerations

  • Alpha-blockers like doxazosin are strongly associated with orthostatic hypotension, especially in older adults 2
  • Avoid doxazosin in patients with standing systolic blood pressure <110 mmHg or pre-existing orthostatic hypotension 2
  • If therapy is discontinued for several days, restart using the initial 1 mg dosing regimen rather than resuming at the previous higher dose 1
  • Measure orthostatic blood pressure by having the patient sit/lie for 5 minutes, then measure BP at 1 and 3 minutes after standing 2

Clinical Efficacy Timeline

  • Significant symptom improvement typically occurs within 1 month, with further improvements continuing through 3 months of therapy 3, 4
  • Mean effective doses in clinical studies were 4 mg daily for normotensive patients and 6.4 mg daily for hypertensive patients 4
  • Long-term efficacy is maintained for up to 48 months with sustained improvement in urinary flow rates and symptom scores 4

Alternative Alpha-Blocker Consideration

  • Tamsulosin has a significantly lower probability of orthostatic hypotension compared to doxazosin and may be preferred in elderly or frail patients at higher risk for falls 2
  • Consider adding a 5-alpha reductase inhibitor (finasteride 5 mg or dutasteride 0.5 mg daily) if prostate volume is >30 cc, as combination therapy may provide additive benefits 5

Common Pitfalls to Avoid

  • Do not skip the titration schedule - jumping directly to higher doses significantly increases the risk of first-dose syncope and orthostatic hypotension 1
  • Do not use doxazosin as first-line in patients already at high fall risk - the 2021 AUA guidelines recommend alpha-blockers as initial therapy, but clinical judgment should prioritize patient safety in frail elderly patients 5, 2
  • Do not combine with another alpha-blocker (like tamsulosin) as this dramatically increases orthostatic hypotension risk without additional BPH benefit 2
  • If orthostatic hypotension develops, switch to an alternative agent (like tamsulosin or a 5-ARI) rather than simply reducing the doxazosin dose 2

Blood Pressure Effects

  • In hypertensive patients, doxazosin produces clinically significant BP reductions (approximately 8/11 mmHg systolic/diastolic) 4
  • In normotensive patients, BP decreases are minimal (approximately 4/2 mmHg) and generally not clinically significant 4, 6
  • Doxazosin can be safely added to existing antihypertensive regimens in patients with controlled hypertension without causing excessive BP reduction 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.